"Open-label, multicenter, single arm, phase II study assessing treatment patient preference for new deferasirox formulation (film-coated tablet) compared to the reference deferasirox dispersible tablet formulation "

drug protocol number
CICL670FIC05
drug sponsor
Novartis
drug study
deferasirox
drug trial site
KAUH-J
drug status
Ongoing
drug phase